Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation

Background: Although immunotherapy has emerged as the “next generation” of cancer treatments, it has not yet been shown to be successful in the treatment of patients with prostate cancer, for whom therapeutic options remain limited to radiotherapy and androgen (hormone) deprivation therapy. Previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Hood, Simon P., Foulds, Gemma A., Imrie, Heather, Reeder, Stephen, McArdle, Stéphanie E. B., Khan, Masood, Pockley, Alan Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362408/
https://www.ncbi.nlm.nih.gov/pubmed/30761160
http://dx.doi.org/10.3389/fimmu.2018.03169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362408/
https://www.ncbi.nlm.nih.gov/pubmed/30761160
http://dx.doi.org/10.3389/fimmu.2018.03169

Ejemplares similares